Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).
作者信息
Singh Akriti, Shaikh Altamash, Singh Ritu, Singh Awadhesh Kumar
机构信息
College of Medicine & JNM Hospital, WBHUS, Kalyani, Nadia, West Bengal, India.
Saifee Hospital, Mumbai, India.
出版信息
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):865. doi: 10.1016/j.dsx.2020.06.012. Epub 2020 Jun 12.
Abstract
摘要
相似文献
1
Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).对辛格和迪巴尔就文章《COVID-19：从实验室到临床》（辛格等人著）致编辑的信的回复信。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):865. doi: 10.1016/j.dsx.2020.06.012. Epub 2020 Jun 12.
2
Letter to editor in response to "COVID-19: From bench to bedside" by Singh A et al.致编辑的信：回应辛格等人所著的《COVID-19：从实验室到临床》
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):815-816. doi: 10.1016/j.dsx.2020.06.018. Epub 2020 Jun 12.
3
Letter to editor in response to article "COVID-19: From bench to bedside" (Singh et al.).致编辑的信：回应文章《COVID-19：从实验室到临床》（辛格等人著）
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):807. doi: 10.1016/j.dsx.2020.06.011. Epub 2020 Jun 10.
4
Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.).对辛格和辛格针对文章《糖尿病与2019冠状病毒病的死亡率及严重程度相关吗？一项荟萃分析》（库马尔等人著）所写信件的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1147-1148. doi: 10.1016/j.dsx.2020.07.002. Epub 2020 Jul 8.
5
Letter in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).针对文章《COVID-19中的合并症：高血压队列的结局及肾素血管紧张素系统阻滞剂相关争议》（辛格等人著）的回应信
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):723-724. doi: 10.1016/j.dsx.2020.05.029. Epub 2020 May 23.
6
Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.).对马哈詹和高尔针对文章《COVID-19中的合并症：高血压队列的结局以及与肾素血管紧张素系统阻滞剂的争议》（辛格等人著）的来信的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):729. doi: 10.1016/j.dsx.2020.05.030. Epub 2020 May 23.
7
Response to letter to the editor by Abhipsha Sur Roy and Amol Joshi regarding the article: 'Multimorbidity and SARS-CoV-2 infection in UK Biobank' (Chudasama et al.).对阿比普莎·苏尔·罗伊和阿莫尔·乔希就文章《英国生物银行中的多重疾病与SARS-CoV-2感染》（楚达萨马等人著）致编辑信的回复
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1281. doi: 10.1016/j.dsx.2020.06.034. Epub 2020 Jun 23.
8
Reply to Chand et al. regarding letter to the Editor regarding the article: 'Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis (Ghoshal et al.)'.针对钱德等人就致编辑的信所作的回复，该信涉及文章《印度新冠疫情封锁期间2型糖尿病风险增加：一项队列分析（戈沙尔等人）》
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):1541. doi: 10.1016/j.dsx.2020.06.058. Epub 2020 Jun 30.
9
10
Response to the letter of L. Santacroce regarding article "Enhancing immunity in viral infections, with special emphasis on COVID-19: A review" (Jayawardena et al.).对L. Santacroce就文章《增强病毒感染中的免疫力，特别关注COVID-19：综述》（Jayawardena等人著）所写信件的回复。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):839. doi: 10.1016/j.dsx.2020.06.017. Epub 2020 Jun 11.
本文引用的文献
1
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis.COVID-19 肺炎：CT 表现的典型特征及鉴别诊断综述。
Diagn Interv Imaging. 2020 May;101(5):263-268. doi: 10.1016/j.diii.2020.03.014. Epub 2020 Apr 3.
2
COVID-19: From bench to bed side.新冠病毒病：从实验室到临床
Diabetes Metab Syndr. 2020 Jul-Aug;14(4):277-281. doi: 10.1016/j.dsx.2020.04.011. Epub 2020 Apr 9.
3
Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease.冠状病毒病（COVID-19）：CT 表现谱及疾病的时间进展。
Acad Radiol. 2020 May;27(5):603-608. doi: 10.1016/j.acra.2020.03.003. Epub 2020 Mar 20.
Zotero 插件